Clinical Trial: Acute Treatment of Vestibular Migraine by Rimegepant

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871097) titled 'Acute Treatment of Vestibular Migraine by Rimegepant' on Nov. 24, 2025.

Brief Summary: To evaluate whether rimegepant improves acute vestibular symptoms and accompanying discomforts in patients with vestibular migraine.

Study Start Date: Dec. 01, 2025

Study Type: INTERVENTIONAL

Condition: Vestibular Migraine

Intervention: DRUG: First dose rimegepant, second dose placebo

First dose rimegepant, second dose placebo

DRUG: First dose placebo, second dose rimegepant

First dose placebo, second dose rimegepant

Recruitment Status: RECRUITING

Sponsor: Wensheng Qu

Information provided by (Responsible Party): Wensheng Qu, Tongji Hos...